Sheard M - Search Results

1

Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.

Zaloudik J, Lauerova L, Janakova L, Talac R, Simickova M, Nekulova M, Mikulikova I, Kovarik J, Sheard M. Zaloudik J, et al. Among authors: sheard m. Hepatogastroenterology. 1999 Jan-Feb;46(25):220-7. Hepatogastroenterology. 1999. PMID: 10228796

2

Cells in the spotlight of cancer research.

Sheard MA. Sheard MA. Folia Biol (Praha). 1998;44(6):221-3. Folia Biol (Praha). 1998. PMID: 10730867 No abstract available.

3

Up-regulation of Fas (CD95) in human p53wild-type cancer cells treated with ionizing radiation.

Sheard MA, Vojtesek B, Janakova L, Kovarik J, Zaloudik J. Sheard MA, et al. Int J Cancer. 1997 Nov 27;73(5):757-62. doi: 10.1002/(sici)1097-0215(19971127)73:5<757::aid-ijc24>3.0.co;2-1. Int J Cancer. 1997. PMID: 9398058 Free article.

4

Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness.

Bencsikova B, Budinska E, Selingerova I, Pilatova K, Fedorova L, Greplova K, Nenutil R, Valik D, Obermannova R, Sheard MA, Zdrazilova-Dubska L. Bencsikova B, et al. Among authors: sheard ma. BMC Cancer. 2019 Jul 15;19(1):687. doi: 10.1186/s12885-019-5909-5. BMC Cancer. 2019. PMID: 31307428 Free PMC article.

5

Biomarkers for predicting response to regional chemo-immunotherapy in liver metastases from colorectal carcinoma.

Zaloudik J, Vagunda V, Drahokoupilova M, Janakova L, Talac R, Kalabis J, Sheard M. Zaloudik J, et al. Among authors: sheard m. Int J Immunopharmacol. 1997 Sep-Oct;19(9-10):481-5. doi: 10.1016/s0192-0561(97)00081-7. Int J Immunopharmacol. 1997. PMID: 9637342

6

Heterogeneous expression of recombination activating genes and surface CD5 in CD3low CD4+ CD8+ thymocytes.

Sheard M, Sugaya K, Furuta M, Tsuda S, Takahama Y. Sheard M, et al. Scand J Immunol. 1996 Jun;43(6):619-25. doi: 10.1046/j.1365-3083.1996.d01-263.x. Scand J Immunol. 1996. PMID: 8658050

7

Synchronous deletion of Mtv-superantigen-reactive thymocytes in the CD3(medium/high) CD4(+)CD8(+) subset.

Sheard MA, Sharrow SO, Takahama Y. Sheard MA, et al. Scand J Immunol. 2000 Dec;52(6):550-4. doi: 10.1046/j.1365-3083.2000.00814.x. Scand J Immunol. 2000. PMID: 11119259 Free article.

8

Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells.

Vondrácek J, Sheard MA, Krejcí P, Minksová K, Hofmanová J, Kozubík A. Vondrácek J, et al. Among authors: sheard ma. J Leukoc Biol. 2001 May;69(5):794-802. J Leukoc Biol. 2001. PMID: 11358989

9

Fractionated gamma-irradiation renders tumour cells more responsive to apoptotic signals through CD95.

Sheard MA, Krammer PH, Zaloudik J. Sheard MA, et al. Br J Cancer. 1999 Aug;80(11):1689-96. doi: 10.1038/sj.bjc.6690585. Br J Cancer. 1999. PMID: 10468284 Free PMC article.

10

Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.

Sheard MA, Uldrijan S, Vojtesek B. Sheard MA, et al. Cancer Res. 2003 Nov 1;63(21):7176-84. Cancer Res. 2003. PMID: 14612511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results